These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 23798998)

  • 21. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
    Rana S; Valbuena GN; Curry E; Bevan CL; Keun HC
    Br J Cancer; 2022 Feb; 126(3):502-513. PubMed ID: 35022525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.
    Spahn M; Kneitz S; Scholz CJ; Stenger N; Rüdiger T; Ströbel P; Riedmiller H; Kneitz B
    Int J Cancer; 2010 Jul; 127(2):394-403. PubMed ID: 19585579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.
    Martens-Uzunova ES; Jalava SE; Dits NF; van Leenders GJ; Møller S; Trapman J; Bangma CH; Litman T; Visakorpi T; Jenster G
    Oncogene; 2012 Feb; 31(8):978-91. PubMed ID: 21765474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
    Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN
    J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatic Analysis and in Vitro Validation of Let-7b and Let-7c in Breast Cancer.
    Bozgeyik E
    Comput Biol Chem; 2020 Feb; 84():107191. PubMed ID: 31901542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
    Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
    J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.
    Aakula A; Kohonen P; Leivonen SK; Mäkelä R; Hintsanen P; Mpindi JP; Martens-Uzunova E; Aittokallio T; Jenster G; Perälä M; Kallioniemi O; Östling P
    Eur Urol; 2016 Jun; 69(6):1120-8. PubMed ID: 26489476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets.
    Rane JK; Scaravilli M; Ylipää A; Pellacani D; Mann VM; Simms MS; Nykter M; Collins AT; Visakorpi T; Maitland NJ
    Eur Urol; 2015 Jan; 67(1):7-10. PubMed ID: 25234358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
    Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
    PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.
    Melbø-Jørgensen C; Ness N; Andersen S; Valkov A; Dønnem T; Al-Saad S; Kiselev Y; Berg T; Nordby Y; Bremnes RM; Busund LT; Richardsen E
    PLoS One; 2014; 9(11):e113039. PubMed ID: 25401698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a.
    Barone I; Gelsomino L; Accattatis FM; Giordano F; Gyorffy B; Panza S; Giuliano M; Veneziani BM; Arpino G; De Angelis C; De Placido P; Bonofiglio D; Andò S; Giordano C; Catalano S
    J Transl Med; 2023 Mar; 21(1):232. PubMed ID: 37004031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
    Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
    Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
    Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
    Peng J; Mo R; Ma J; Fan J
    World J Surg Oncol; 2015 May; 13():175. PubMed ID: 25951903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.